Skip to content

VISULAS green (UDI 04049471091441)Recalls & reported problems

Carl Zeiss Meditec AG · VISULAS green is intended for use in photocoagulation of tissues in the posterior and anterior segments of the eye including trabeculoplasty and iridotomy. The DI number characterizes the laser console which has a dual fiber port. The laser console with dual fiber port forms part of both models, VISULAS green classic and VISULAS green comfort. · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04049471091441), received between Sep 26, 2024 and Oct 24, 2024 — classified as 2 injuries.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Use of Device Problem1

Patient problems

  • Intraocular Pressure Increased2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 24, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PRIMARY OPEN-ANGLE GLAUCOMA (POAG) PATIENT SUFFERED FROM A PERSISTING INCREASE IN INTRAOCULAR PRESSURE (IOP) AFTER SELECTIVE LASER TRABECULOPLASTY (SLT) TREATMENT. IT WAS FURTHER REPORTED THAT THE NUMBER OF GLAUCOMA MEDICATIONS HAD TO BE INCREASED FROM 2 TO 3.

    Patient problems: Intraocular Pressure Increased

    MAUDE report 20526971 ↗
  • InjurySep 26, 2024Use of Device Problem; Use of Device Problem

    IT WAS REPORTED THAT A PATIENT SUFFERED FROM UNCONTROLLABLE RISE OF INTRAOCULAR PRESSURE (IOP) AFTER SELECTIVE LASER TRABECULOPLASTY (SLT) TREATMENT. WHILE A TRANSIENT IOP RISE IS A COMMON SIDE EFFECT, THIS SPECIFIC PATIENT NEEDED AN INCREASE OF MEDICATION (FROM ONE DRUG TO TWO) DUE TO INSUFFICIENT IOP CONTROL AFTER THE SPIKE. THREE MONTHS AFTER LASER TREATMENT THIS PATIENT NEEDED A SURGERY BECAUSE OF UNCONTROLLED IOP AND INABILITY FOR FURTHER INCREASE OF TOPICAL MEDICATION DUE TO MULTIPLE DRUGS INTOLERANCES. THE SURGERY PERFORMED WAS AN UNEVENTFUL PHACO-MIGS. THE IOP AT SIX MONTHS LASER TREATMENT FOLLOW UP WAS 12 MM HG (BASELINE IOP OF 29 MMHG)

    Patient problems: Intraocular Pressure Increased

    MAUDE report 20311563 ↗

Other Laser, Ophthalmic devices

All Laser, Ophthalmic devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.